Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis: Editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
Hyuk soo Eun
Clin Mol Hepatol. 2025;31(2):599-602.   Published online 2024 Dec 26     DOI: https://doi.org/10.3350/cmh.2024.1133
Citations to this article as recorded by Crossref logo
Correspondence to editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
Yang Liu, Fan Peng, Siyuan Wang, Jinliang Xing
Clinical and Molecular Hepatology.2025; 31(2): e166.     CrossRef
Reply to correspondence on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
Hyuk Soo Eun
Clinical and Molecular Hepatology.2025; 31(2): e215.     CrossRef